Authors:
WIKSTRAND CJ
REIST CJ
ARCHER GE
ZALUTSKY MR
BIGNER DD
Citation: Cj. Wikstrand et al., THE CLASS-III VARIANT OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFRVIII) - CHARACTERIZATION AND UTILIZATION AS AN IMMUNOTHERAPEUTIC TARGETS, Journal of neurovirology, 4(2), 1998, pp. 148-158
Citation: Ml. Hauck et Mr. Zalutsky, THE EFFECTS OF LOCAL HYPERTHERMIA ON THE CATABOLISM OF A RADIOIODINATED CHIMERIC MONOCLONAL-ANTIBODY, Clinical cancer research, 4(9), 1998, pp. 2071-2077
Citation: Cj. Reist et al., HUMAN IGG2 CONSTANT-REGION ENHANCES IN-VIVO STABILITY OF ANTI-TENASCIN ANTIBODY 81C6 COMPARED WITH ITS MURINE PARENT, Clinical cancer research, 4(10), 1998, pp. 2495-2502
Citation: G. Vaidyanathan et al., IODOPYRIDINE-FOR-IODOBENZE SUBSTITUTION FOR USE WITH LOW-MOLECULAR-WEIGHT RADIOPHARMACEUTICALS - APPLICATION TO M-IODOBENZYLGUANIDINE, Bioconjugate chemistry, 9(6), 1998, pp. 758-764
Authors:
DEGRADO TR
ZALUTSKY MR
COLEMAN RE
VAIDYANATHAN G
Citation: Tr. Degrado et al., EFFECTS OF SPECIFIC ACTIVITY ON META-[I-131]IODOBENZYLGUANIDINE KINETICS IN ISOLATED RAT-HEART, Nuclear medicine and biology, 25(1), 1998, pp. 59-64
Citation: G. Vaidyanathan et Mr. Zalutsky, PREPARATION OF 1-(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)URACIL AND1-(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)URACIL BY A HALODESTANNYLATION REACTION, Nuclear medicine and biology, 25(5), 1998, pp. 487-496
Citation: Rh. Larsen et al., BLOCKING [AT-211]ASTATIDE ACCUMULATION IN NORMAL-TISSUES - PRELIMINARY EVALUATION OF 7 POTENTIAL COMPOUNDS, Nuclear medicine and biology, 25(4), 1998, pp. 351-357
Citation: Cf. Foulon et al., ASTATINE-211-LABELED BIOTIN CONJUGATES RESISTANT TO BIOTINIDASE FOR USE IN PRETARGETED RADIOIMMUNOTHERAPY, Nuclear medicine and biology, 25(2), 1998, pp. 81-88
Authors:
BIGNER DD
BROWN MT
FRIEDMAN AH
COLEMAN RE
AKABANI G
FRIEDMAN HS
THORSTAD WL
MCLENDON RE
BIGNER SH
ZHAO XG
PEGRAM CN
WIKSTRAND CJ
HERNDON JE
VICK NA
PALEOLOGOS N
COKGOR I
PROVENZALE JM
ZALUTSKY MR
Citation: Dd. Bigner et al., IODINE-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 TREATMENT OFPATIENTS WITH RECURRENT MALIGNANT GLIOMAS - PHASE-I TRIAL RESULTS, Journal of clinical oncology, 16(6), 1998, pp. 2202-2212
Authors:
BERRY CR
VAIDYANATHAN G
FISHER PE
ZALUTSKY MR
COLEMAN RE
DEGRADO TR
Citation: Cr. Berry et al., MYOCARDIAL KINETICS OF META-[I-131]IODOBENZYLGUANIDINE IN AN ADRIAMYCIN CARDIOMYOPATHY RAT MODEL, The Journal of nuclear medicine, 39(5), 1998, pp. 177-177
Citation: Cj. Reist et al., HUMAN IGG(2) CONSTANT-REGION ENHANCES THE IN-VIVO STABILITY OF MONOCLONAL-ANTIBODY 81C6 COMPARED TO ITS MURINE PARENT, The Journal of nuclear medicine, 39(5), 1998, pp. 297-297
Citation: G. Valdyanathan et al., N.C.A. -1(2-DEOXY,2-FLUORO-BETA-D-ARABINOFURANOSYL)URACIL (FIAU) - TISSUE UPTAKE IN D-54 GLIOMA XENOGRAFT MOUSE MODEL AND CYTOTOXICITY TO D-247 GLIOMA-CELLS IN-VITRO, The Journal of nuclear medicine, 39(5), 1998, pp. 408-408
Citation: Cf. Foulon et al., PRETARGETED RADIOIMMUNOTHERAPY USING ANTI-TENASCIN 81C6-STREPTAVIDIN CONJUGATES AND RADIOLABELED BIOTIN - PREPARATION OF REAGENTS, The Journal of nuclear medicine, 39(5), 1998, pp. 412-412
Authors:
WALICKA MA
VAIDYANATHAN G
ZALUTSKY MR
ADELSTEIN SJ
KASSIS AI
Citation: Ma. Walicka et al., SURVIVAL AND DNA-DAMAGE IN CHINESE-HAMSTER V79 CELLS EXPOSED TO ALPHA-PARTICLES EMITTED BY DNA-INCORPORATED ASTATINE-211, Radiation research, 150(3), 1998, pp. 263-268
Citation: Rh. Larsen et al., THE CYTOTOXICITY AND MICRODOSIMETRY OF ASTATINE-211-LABELED CHIMERIC MONOCLONAL-ANTIBODIES IN HUMAN GLIOMA AND MELANOMA-CELLS IN-VITRO, Radiation research, 149(2), 1998, pp. 155-162
Authors:
COKGOR I
AKABANI G
BROWN MT
FRIEDMAN AH
COLEMAN RE
FRIEDMAN HS
THORSTAD WL
MCLENDON RE
BIGNER SH
ZHAO XG
PEGRAM CN
WIKSTRAND CJ
HERNDON JE
VICK NA
PALEOLOGOS N
ZALUTSKY MR
BIGNER DD
Citation: I. Cokgor et al., RESULTS OF A PHASE-I TRIAL OF PATIENTS WITH RECURRENT BRAIN-TUMORS AND PRIOR RADIATION-THERAPY TREATED WITH I-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 VIA SURGICALLY CREATED RESECTION CAVITIES, Neurology, 50(4), 1998, pp. 52005-52005
Citation: Ml. Hauck et al., CYTOTOXICITY OF ALPHA-PARTICLE EMITTING ASTATINE-211-LABELED ANTIBODYIN TUMOR SPHEROIDS - NO EFFECT OF HYPERTHERMIA, British Journal of Cancer, 77(5), 1998, pp. 753-759
Authors:
CUNNINGHAM SH
MAIRS RJ
WHELDON TE
WELSH PC
VAIDYANATHAN G
ZALUTSKY MR
Citation: Sh. Cunningham et al., TOXICITY TO NEUROBLASTOMA-CELLS AND SPHEROIDS OF BENZYLGUANIDINE CONJUGATED TO RADIONUCLIDES WITH SHORT-RANGE EMISSIONS, British Journal of Cancer, 77(12), 1998, pp. 2061-2068
Authors:
HAUCK ML
DEWHIRST MW
BIGNER DD
ZALUTSKY MR
Citation: Ml. Hauck et al., LOCAL HYPERTHERMIA IMPROVES UPTAKE OF A CHIMERIC MONOCLONAL-ANTIBODY IN A SUBCUTANEOUS XENOGRAFT MODEL, Clinical cancer research, 3(1), 1997, pp. 63-70
Citation: G. Vaidyanathan et al., METHOD FOR RADIOIODINATION OF PROTEINS USING N-SUCCINIMIDYL 3-HYDROXY-4-IODOBENZOATE, Bioconjugate chemistry, 8(5), 1997, pp. 724-729
Citation: Cf. Foulon et al., SYNTHESIS AND PRELIMINARY BIOLOGICAL EVALUATION OF (3-IODOBENZOYL)NORBIOTINAMIDE AND ((5-IODO-3-PYRIDINYL)CARBONYL)NORBIOTINAMIDE - 2 RADIOIODINATED BIOTIN CONJUGATES WITH IMPROVED STABILITY, Bioconjugate chemistry, 8(2), 1997, pp. 179-186
Authors:
REIST CJ
BATRA SK
PEGRAM CN
BIGNER DD
ZALUTSKY MR
Citation: Cj. Reist et al., IN-VITRO AND IN-VIVO BEHAVIOR OF RADIOLABELED CHIMERIC ANTI-EGFRVIII MONOCLONAL-ANTIBODY - COMPARISON WITH ITS MURINE PARENT, Nuclear medicine and biology, 24(7), 1997, pp. 639-647
Citation: Mr. Zalutsky et al., TISSUE DISTRIBUTION AND RADIATION-DOSIMETRY OF ASTATINE-211-LABELED CHIMERIC 81C6, AN ALPHA-PARTICLE-EMITTING IMMUNOCONJUGATE, Nuclear medicine and biology, 24(3), 1997, pp. 255-261
Citation: Cf. Foulon et al., PREPARATION AND BIOLOGICAL EVALUATION OF AN ASTATINE-211 LABELED BIOTIN CONJUGATE - BIOTINYL-3-[AT-211]ASTATOANILIDE, Nuclear medicine and biology, 24(2), 1997, pp. 135-143